Evaluation of Quality Metrics in Vestibular Schwannoma Surgery Outcomes

Overview

This study assessed the effectiveness of current quality metrics in evaluating postoperative complications following vestibular schwannoma (VS) surgery. It highlighted limitations of standard 30-day postoperative measures and emphasized the need for longer observation periods and tumor-specific quality indicators.

Background

Vestibular schwannomas are benign tumors arising from Schwann cells of the vestibular nerve, with surgical resection posing challenges in preserving facial and hearing functions. Advances in microsurgical techniques have improved mortality and morbidity rates, but standardized quality measures remain crucial for risk stratification and reimbursement decisions. Existing quality indicators primarily focus on the first 30 postoperative days and are generalized across neurosurgical procedures, potentially overlooking VS-specific outcomes. This study aimed to evaluate these metrics' applicability to VS surgery and identify risk factors associated with adverse outcomes.

Data Highlights

The study retrospectively included patients undergoing microsurgical VS resection from 2013 to 2019, excluding neurofibromatosis type II and bilateral VS cases. Outcomes assessed included 30- and 90-day reoperation, readmission, mortality, infections, CSF leaks, hearing, and facial nerve function. Tumor size, extent of resection, and comorbidities were analyzed as potential risk factors. Facial nerve function was graded by House & Brackman classification, and hearing by Gardner Robertson scale. Statistical analyses involved chi-square, t-tests, Mann–Whitney U tests, and multivariable logistic regression to identify significant predictors of adverse events.

Key Findings

• Current quality metrics focusing on 30-day postoperative outcomes may underestimate complications related to VS surgery, suggesting the need for extended follow-up periods.
• Facial nerve preservation remains a critical challenge, with new persistent facial nerve dysfunction defined as House & Brackman grade III or higher lasting beyond 3 months.
• Extent of tumor resection (complete, near total, subtotal) influences postoperative outcomes and recurrence rates.
• Comorbidities assessed by the Charlson comorbidity index and age-adjusted CCI are important in risk stratification for postoperative complications.
• Unplanned reoperations and readmissions were primarily due to CSF leaks, surgical site infections, and new facial palsy.
• Multimodal intraoperative neuromonitoring of cranial nerves V, VII, and VIII is integral to surgical strategy aiming to maximize tumor resection while preserving nerve function.

Clinical Implications

Clinicians should consider extending postoperative monitoring beyond the conventional 30-day window to capture late-occurring complications in VS surgery. Incorporating tumor-specific risk factors and comorbidity profiles into quality metrics may improve risk stratification and patient counseling. Multimodal intraoperative neuromonitoring remains essential to optimize functional outcomes.

Conclusion

Standard neurosurgical quality metrics inadequately capture the full spectrum of postoperative complications in vestibular schwannoma surgery. Tailored, disease-specific quality indicators with longer observation periods are necessary to better assess surgical outcomes and guide clinical decision-making.

References

1. House & Brackman 1985 -- Facial nerve grading system
2. Gardner Robertson 1988 -- Hearing classification scale
3. Charlson et al. 1987 -- Comorbidity index development
4. University Hospital Münster 2013-2019 -- Vestibular schwannoma surgery data